Skip to Content

Overall survival in patients with advanced stage Hodgkin’s Lymphoma improves on Brentuximab Vedotin

Brentuximab Vedotin plus chemotherapy as first-line treatment improves the overall survival in patients suffering from stage III or IV Hodgkin’s Lymphoma. Get an update on the ECHELON-1 trial by investigator Stephen Ansell in this MEDtalk.

Stephen Ansell

Få tilgang til artikkelen

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top